tiprankstipranks
Trending News
More News >
Emimen Co.,Ltd. (JP:9237)
:9237
Japanese Market

Emimen Co.,Ltd. (9237) AI Stock Analysis

Compare
0 Followers

Top Page

JP:9237

Emimen Co.,Ltd.

(9237)

Select Model
Select Model
Select Model
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
,
Neutral 61 (OpenAI - 5.2)
Rating:61Neutral
Price Target:
¥806.00
▼(-62.94% Downside)
Action:ReiteratedDate:03/19/26
The score is driven primarily by improved underlying financial health (growth, profitability turnaround, and stronger leverage position), partially offset by the latest-year deterioration in margins and cash conversion. Technicals further weigh on the score due to a clear downtrend versus key moving averages and a negative MACD, while valuation is moderately supportive with a mid-teens P/E.
Positive Factors
Sustained Revenue Growth
Multi-year top-line expansion and a sharp 2025 revenue lift demonstrate scalable demand and market traction. Durable revenue growth supports reinvestment, scale economies, and resilience vs cyclical swings, providing a structural base for future margin recovery and capital generation.
Improved Balance Sheet / Low Leverage
A materially lower debt-to-equity and growing equity base reduce financial risk and increase strategic optionality. This improved capital structure boosts funding flexibility for investments or acquisitions and lowers refinancing vulnerability over the medium term, strengthening durability.
Historically Positive Free Cash Flow
Consistent positive FCF in prior years shows the business can convert profits to cash to fund operations, capex, and deleveraging. While 2025 weakened conversion, the historical cash generation track record is a durable strength if margins stabilize.
Negative Factors
Sharp 2025 Margin Compression
A large drop in margins materially weakens earnings power and return on capital, reducing internal funding for growth and debt reduction. If margin erosion persists, it undermines the benefits of revenue growth and pressures long-term profitability resilience.
Deteriorated Cash Conversion in 2025
Lower operating cash flow and reduced FCF coverage shrink liquidity and the firm's ability to self-fund investments or cushion shocks. Persistent weak cash conversion would force reliance on external financing and could reverse recent balance-sheet gains.
Cyclic History of High Leverage
Prior episodes of high leverage indicate the balance sheet can quickly deteriorate under stress. Combined with current margin and cash risks, recurrence of weak earnings could re-elevate leverage, increasing refinancing risk and constraining strategic choices over the medium term.

Emimen Co.,Ltd. (9237) vs. iShares MSCI Japan ETF (EWJ)

Emimen Co.,Ltd. Business Overview & Revenue Model

Company DescriptionEmimen Co., Ltd. provides senior home introduction services for the elderly in Japan. It offers support services for moving into senior homes and information on senior homes; and senior home management consulting services, such as care prime community site management and new senior home opening consulting. The company was incorporated in 2010 and is headquartered in Osaka, Japan.

Emimen Co.,Ltd. Financial Statement Overview

Summary
Strong multi-year revenue growth and a clear turnaround to profitability, with a much healthier balance sheet (low debt-to-equity) supporting overall strength. The key drag is 2025’s sharp margin compression and weaker cash conversion (lower operating cash flow and free cash flow covering a smaller share of net income).
Income Statement
72
Positive
Revenue has scaled rapidly over the past several years, accelerating sharply in 2025 (annual revenue up ~119%). Profitability improved materially from 2021 losses to solid profits in 2022–2024, but 2025 shows a notable step-down in earnings power: net margin fell to ~4.8% (vs. ~13.8% in 2024) and operating margin also compressed meaningfully. Strength is strong top-line momentum; key weakness is the sharp margin and net income decline in the latest year.
Balance Sheet
82
Very Positive
Leverage has improved dramatically versus 2021–2022 when equity was very small and debt levels looked elevated relative to equity. By 2023–2025, the balance sheet appears much healthier with low debt versus equity (debt-to-equity ~0.15–0.29) and expanding equity base alongside asset growth. Return on equity remains positive in recent years (though it moderated in 2025), suggesting profits are still supporting capital. Main risk: the business has a history of very high leverage during weaker periods, so maintaining profitability is important to keep the balance sheet strong.
Cash Flow
58
Neutral
Cash generation was strong in 2022–2024, with free cash flow generally close to net income and positive growth. However, 2025 shows weaker cash conversion: operating cash flow dropped to ~¥76.8M and free cash flow to ~¥47.1M, with free cash flow covering only ~61% of net income (down from ~89% in 2024). Strength is consistently positive free cash flow in recent years; weakness is the 2025 deterioration in operating cash flow and cash-to-profit quality.
BreakdownTTMOct 2025Oct 2024Oct 2023Oct 2022Oct 2021
Income Statement
Total Revenue855.65M1.87B1.30B814.29M609.70M429.92M
Gross Profit29.27M935.85M916.68M581.74M391.10M267.53M
EBITDA32.80M123.22M222.17M118.08M26.99M-73.60M
Net Income38.28M89.67M179.65M105.96M35.02M-78.53M
Balance Sheet
Total Assets1.21B1.38B1.13B789.28M312.76M271.42M
Cash, Cash Equivalents and Short-Term Investments766.16M657.26M761.02M590.56M192.99M191.44M
Total Debt103.59M125.53M116.23M135.58M147.65M177.88M
Total Liabilities448.53M570.00M410.30M324.89M273.75M267.43M
Stockholders Equity758.31M813.47M720.62M464.39M39.01M3.99M
Cash Flow
Free Cash Flow18.00M47.06M147.13M104.21M37.23M-78.00M
Operating Cash Flow24.00M76.77M158.14M104.83M38.29M-75.44M
Investing Cash Flow-14.00M-201.68M-44.61M-9.36M-6.34M-6.58M
Financing Cash Flow-5.50M13.96M56.94M303.11M-30.39M8.87M

Emimen Co.,Ltd. Technical Analysis

Technical Analysis Sentiment
Negative
Last Price2175.00
Price Trends
50DMA
883.48
Negative
100DMA
934.42
Negative
200DMA
1048.35
Negative
Market Momentum
MACD
-17.20
Positive
RSI
34.48
Neutral
STOCH
57.89
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:9237, the sentiment is Negative. The current price of 2175 is above the 20-day moving average (MA) of 864.00, above the 50-day MA of 883.48, and above the 200-day MA of 1048.35, indicating a bearish trend. The MACD of -17.20 indicates Positive momentum. The RSI at 34.48 is Neutral, neither overbought nor oversold. The STOCH value of 57.89 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:9237.

Emimen Co.,Ltd. Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
78
Outperform
¥13.39B14.722.91%7.68%39.87%
71
Outperform
¥4.82B3.410.36%
63
Neutral
$10.79B15.437.44%2.01%2.89%-14.66%
61
Neutral
¥3.11B14.8943.89%-50.27%
57
Neutral
¥4.46B13.18-4.85%-41.71%
54
Neutral
¥6.03B19.88-1.71%-303.36%
46
Neutral
¥1.48B23.808.62%-658.96%
* Industrials Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:9237
Emimen Co.,Ltd.
733.00
-219.50
-23.04%
JP:4422
VALUENEX Japan Inc.
475.00
272.67
134.76%
JP:4490
VisasQ, Inc.
523.00
-510.00
-49.37%
JP:6035
IR Japan Holdings Ltd.
735.00
0.60
0.08%
JP:9236
Japan M&A Solution Incorporated
1,001.00
-173.00
-14.74%
JP:9246
ProjectHoldings.Inc.
1,100.00
-228.00
-17.17%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Mar 19, 2026